Your browser doesn't support javascript.
loading
[Consistency of ALK Ventana-D5F3 immunohistochemistry interpretation in lung adenocarcinoma among Chinese histopathologists].
Li, L; Zhang, L P; Han, Y C; Wang, W Y; Jin, Y; Xia, Q X; Liu, Y P; Xiang, J; Liu, C; Lu, S S; Wu, W; Chen, Z; Pang, J; Xi, Y F; Zheng, Y S; Gu, D M; Fan, J; Chang, X N; Wang, W W; Wang, L; Zhang, Z H; Yan, X C; Sun, Y; Li, J; Hou, F; Zhang, J Y; Huang, R F; Lu, J P; Wang, Z; Hu, Y B; Yuan, H T; Dong, Y J; Wang, L; Ke, Z Y; Geng, J S; Guo, L; Zhang, J; Ying, J M.
Afiliação
  • Li L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Zhang LP; Department of Pathology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • Han YC; Department of Pathology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China.
  • Wang WY; Department of Pathology, West China Hospital of Sichuan University, Chengdu 610041, China.
  • Jin Y; Department of Pathology, Fudan University Cancer Center; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai 200032, China.
  • Xia QX; Department of Molecular Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Liu YP; Department of Pathology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
  • Xiang J; Department of Pathology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Liu C; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
  • Lu SS; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Wu W; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Chen Z; Department of Pathology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • Pang J; Department of Pathology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China.
  • Xi YF; Department of Pathology, West China Hospital of Sichuan University, Chengdu 610041, China.
  • Zheng YS; Department of Pathology, Fudan University Cancer Center; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai 200032, China.
  • Gu DM; Department of Pathology, Fudan University Cancer Center; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai 200032, China.
  • Fan J; Department of Molecular Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Chang XN; Department of Molecular Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Wang WW; Department of Pathology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
  • Wang L; Department of Pathology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Zhang ZH; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
  • Yan XC; Institute of Pathology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
  • Sun Y; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Li J; Department of Pathology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • Hou F; Department of Pathology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China.
  • Zhang JY; Department of Pathology, West China Hospital of Sichuan University, Chengdu 610041, China.
  • Huang RF; Department of Pathology, Fudan University Cancer Center; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai 200032, China.
  • Lu JP; Department of Pathology, Fudan University Cancer Center; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai 200032, China.
  • Wang Z; Department of Molecular Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Hu YB; Department of Pathology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
  • Yuan HT; Department of Pathology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Dong YJ; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
  • Wang L; Department of Pathology, Xijing Hospital, Air Force Military Medical University, Xi'an 710032, China.
  • Ke ZY; Department of Pathology, Xijing Hospital, Air Force Military Medical University, Xi'an 710032, China.
  • Geng JS; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Guo L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Zhang J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Ying JM; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhonghua Bing Li Xue Za Zhi ; 48(12): 921-927, 2019 Dec 08.
Article em Zh | MEDLINE | ID: mdl-31818064
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imuno-Histoquímica / Adenocarcinoma de Pulmão / Quinase do Linfoma Anaplásico / Neoplasias Pulmonares Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imuno-Histoquímica / Adenocarcinoma de Pulmão / Quinase do Linfoma Anaplásico / Neoplasias Pulmonares Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Ano de publicação: 2019 Tipo de documento: Article